Patience C. Ogbozor
Director/Board Member bij KID CASTLE EDUCATIONAL CORPORATION
Profiel
Ms. Patience C.
Ogbozor is a President, Chief Executive Officer & Director at Cannabinoid Biosciences, Inc. She is on the Board of Directors at Opportunity Zone Capital LLC, GiveMePower Corp., Kid Castle Educational Corp., Video River Networks, Inc., Goldstein Franklin, Inc. and Cannabinoid Biosciences, Inc.
Actieve functies van Patience C. Ogbozor
| Bedrijven | Functie | Begin |
|---|---|---|
| KID CASTLE EDUCATIONAL CORPORATION | Director/Board Member | 23-10-2019 |
| GIVEMEPOWER CORPORATION | Director/Board Member | 01-12-2019 |
| VIDEO RIVER NETWORKS, INC. | Director/Board Member | 01-10-2019 |
Cannabinoid Biosciences, Inc.
 Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Chief Executive Officer | 01-11-2018 |
| Goldstein Franklin, Inc. | Director/Board Member | 01-06-2015 |
| Opportunity Zone Capital LLC | Director/Board Member | 18-02-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| KID CASTLE EDUCATIONAL CORPORATION | Commercial Services |
| GIVEMEPOWER CORPORATION | Technology Services |
| VIDEO RIVER NETWORKS, INC. | Electronic Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cannabinoid Biosciences, Inc.
Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Health Technology |
| Goldstein Franklin, Inc. | |
| Opportunity Zone Capital LLC |
